Search

everythinglearnresearchcommunity

for

Search:↓

A new method effectively predicts estrogen-related health effects for early screening.

Androgens may worsen a natural hair resting phase, possibly leading to hair loss.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Altered DHEA metabolism in hair follicles may be linked to hair loss in balding men.

Testosterone and dihydrotestosterone can slow down the growth of certain hair follicle cells.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Higher sulfotransferase enzyme levels predict better response to minoxidil for hair growth.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Finasteride is safe and effective for hair loss in transgender men, but may affect testosterone therapy.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.

Lower vitamin D levels are linked to more severe hair loss in men.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Diode laser treatment works better for facial hirsutism in patients with normal hormone levels.

Check hormone levels in older women to find hidden conditions like certain tumors.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

A young girl's hyperandrogenism was caused by an adrenocortical adenoma, diagnosed and treated through detailed evaluations.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

The treatment slightly increased hair growth and was safe for most women.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.

Testosterone and dihydrotestosterone slow hair cell growth, while estradiol has no effect.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Topical finasteride may help treat facial hirsutism in women.